Skip to content

The Effect and Mechanism of Electroacupuncture on Acute Chemotherapy-induced Nausea and Vomiting

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02469493
Enrollment
160
Registered
2015-06-11
Start date
2015-01-31
Completion date
Unknown
Last updated
2015-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms

Brief summary

The purpose of this study is to compare the preventive effect of electroacupuncture and sham acupuncture on acute chemotherapy-induced nausea and vomiting and then investigate its potential mechanism by using functional Magnetic Resonance Imaging (fMRI).

Interventions

DEVICEacupuncture (Huatuo)

The needles used were Huatuo brand (Suzhou, China) sterile disposable stainless steel filiform; needles sized 0.25\*25 mm. After disinfection, needles were inserted 0.5 to 0.8 inches into the skin and were manipulated manually to obtain Deqi. An electric stimulator (Huatuo SDZ-V, Suzhou, China) was connected to the needles and delivered a constant-current, 0.2-ms, density-wave, stimulus of 2 to 10-Hz frequency, level of intensity was as much as tolerable, but not painful to the subjects. The needles were left for 30 minutes and then removed.

Sponsors

Xidian University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* First diagnosed stage Ⅲ-Ⅳ lung cancer patients on cisplatin chemotherapy; * Right-handed and aged 18 to 75 years; * Karnosky performance status (KPS) ≥ 70; * Life expectancy ≥ 6 months.

Exclusion criteria

* Had brain metastases or other concurrent life-threatening diseases; * Nausea and/or vomiting were present 24h before chemotherapy treatment; * Suffered from or had a history of gastrointestinal diseases; * Had a history of head trauma, serious neurological or psychiatric disorders; * Participating in other clinical trials currently; * Had any contraindication to exposure to a high magnetic field or receive acupuncture

Design outcomes

Primary

MeasureTime frame
The scores of Rhodes Index of Nausea, Vomiting and Retching.24 hours

Secondary

MeasureTime frame
Content of 5-hiaa in urine12 hours
Heart Rate Variability1 hour
Tachygastria percentage1 hour
Dosage of antiemetic drugs24 hours

Other

MeasureTime frame
Neuroimaging data24 hours

Countries

China

Contacts

Primary ContactJin, Doctor
king-jlm@163.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026